National and Kapodistrian University of Athens
Σύγκριση της επίδρασης των αναστολέων της ιντεγκράσης και των αναστολέων της πρωτεάσης στη μείωση της ανοσολογικής διέγερσης και στη βακτηριακή αλλόθεση, σε HIV (+) άτομα υπο αγωγή και που έχουν πετύχει αριθμό CD4+>350/μL και μη ανιχνεύσιμο ιικό φορτίο για τουλάχιστον πάνω απο 6 μήνες
Abstract
dc:descriptionBackground and Objectives: The success of combined antiretroviral therapy (cART) has led to a dramatic improvement in the life expectancy of people living with HIV (PLWH). However, there has been an observed increase in cardiometabolic, bone, renal, hepatic, and neurocognitive manifestations, as well as neoplasms, known as serious non-AIDS events/SNAEs, compared to the general population of corresponding age. This increase is linked to a harmful phenomenon called inflammaging/immunosenescence, which is driven by chronic immune activation and intestinal bacterial translocation. In this study, we examined immunological and metabolic parameters in individuals receiving current cART. Materials and Methods: The study was conducted at Laiko General Hospital in Athens, Greece. Plasma concentrations of sCD14, IL-6, SuPAR, I-FABP, and LBP were measured in virally suppressed PLWH under cART with at least 350 CD4+ lymphocytes/µL. We compared these levels between PLWH receiving integrase strand transfer inhibitors (INSTIs) and protease inhibitors (PIs) and attempted to correlate them with chronic immune activation and metabolic parameters. Results: Data from 28 PLWH were analyzed, with a mean age of 52 and 93% being males. Among the two comparison groups, IL-6 levels were higher in the PIs group (5.65 vs. 7.11 pg/mL, p = 0.03). No statistically significant differences were found in the other measured parameters. A greater proportion of PLWH under INSTIs had normal-range LBP (33% vs. 0%, p = 0.04). When using inverse probability of treatment weighting, no statistically significant differences in the measured parameters were found between the two groups (sCD14 p = 0.511, IL-6 p = 0.383, SuPAR p = 0.793, I-FABP p = 0.868, and LBP p = 0.663). Glucose levels were found to increase after viral suppression in the entire sample (92 mg/dL vs. 98 mg/dL, p = 0.009). Total (191 mg/dL vs. 222 mg/dL, p = 0.005) and LDL cholesterol (104 mg/dL vs. 140 mg/dL, p = 0.002) levels were higher in the PIs group. No significant differences were observed in liver and renal function tests. Conclusions: Further investigation is warranted for PLWH on cART-containing INSTIs regimens to explore potential reductions in chronic immune activation and intestinal bacterial translocation.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2024
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Nitsotolis, Thomas
- Νιτσοτόλης, Θωμάς
Subjects
dc:subject × 16- Χρόνια ανοσολογική διέγερση
- Εντερική βακτηριακή αλλόθεση
- Αναστολείς ιντεγκράσης
- Αναστολείς πρωτεάσης
- Mη ανιχνεύσιμο ιικό φορτίο για τουλάχιστον πάνω από 6 μήνες
- Chronic immune activation
- Intestinal bacterial translocation
- Integrase strand transfer inhibitors (INSTIs)
- Protease-boosted inhibitors (PIs)
- In a virally suppressed, mainly male population living with HIV (PLWH)
- Επιστήμες Υγείας
- Ιατρική και Επιστήμες Υγείας
- Λοιμώδη νοσήματα
- Health Sciences
- Medical and Health Sciences
- Infectious Diseases
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/56508